Overall, NCI obligations for its extramural program, including grants and contracts, totaled $5.46 billion in fiscal year 2025.
- Obligations for grants totaled approximately 86.3% of extramural funding
- Obligations for contracts totaled approximately 13.7% of extramural funding
| Mechanism | Amount | Percent |
|---|---|---|
| Research & Development (R&D) Contracts | $718,779,728 | 13.2% |
| Buildings and Facilities | $30,000,000 | 0.5% |
| Construction Contracts | $0 | 0.0% |
| Subtotal Contracts | $748,779,728 | 13.7% |
| Research Project Grants (RPGs) | $3,414,667,359 | 62.5% |
| Cancer Centers/Specialized Centers/SPORES | $607,075,632 | 11.1% |
| NRSA | $80,642,468 | 1.5% |
| Other Research Grants | $615,923,395 | 11.3% |
| Subtotal Grants | $4,718,308,854 | 86.3% |
| Total Extramural Funds | $5,465,634,711 | 100.0% |
| Intramural/RMS Funds | $1,755,345,352 | |
| *Total NCI | $7,220,980,063 | |
| *Includes FY 2022 Cures Moonshot funding. *Excludes fiscal years 2017 through 2021 Cures Moonshot carryover obligations. | ||